Sana Biotechnology (SANA) Other Non Operating Income (2020 - 2026)
Sana Biotechnology (SANA) reported Other Non Operating Income of $453000.0 for Q1 2026, up 81.93% on a YoY basis from $249000.0 in Q1 2025, and down 58.74% sequentially from $1.1 million in Q4 2025.
Sana Biotechnology (SANA) Other Non Operating Income (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of Other Non Operating Income data on file, last reported at $453000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 81.93% year-over-year to $453000.0; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 156.09% YoY), and the FY2025 full-year result was $2.3 million, up 151.14% from the prior year.
- Other Non Operating Income slipped to $453000.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q4 2025 to a low of -$4.1 million in Q2 2024.
- A 5-year average of -$145588.2 and a median of -$47000.0 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income slumped 19900.0% in 2022 and soared 678.72% in 2025, its largest moves.
- Tracing SANA's Other Non Operating Income over 5 years: stood at -$268000.0 in 2022, then climbed by 16.42% to -$224000.0 in 2023, then jumped by 162.95% to $141000.0 in 2024, then soared by 678.72% to $1.1 million in 2025, then plunged by 58.74% to $453000.0 in 2026.
- Business Quant data shows SANA's Other Non Operating Income at $453000.0 in Q1 2026, $1.1 million in Q4 2025, and $360000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sana Biotechnology | 888.71 Mn | 888.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 453,000.00 |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 360,000.00 |
| Jun 30, 2025 | 598,000.00 |
| Mar 31, 2025 | 249,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | -742,000.00 |
| Jun 30, 2024 | -4.12 Mn |
| Mar 31, 2024 | 215,000.00 |
| Dec 31, 2023 | -224,000.00 |
| Sep 30, 2023 | 303,000.00 |
| Jun 30, 2023 | -84,000.00 |
| Mar 31, 2023 | -47,000.00 |
| Dec 31, 2022 | -268,000.00 |
| Sep 30, 2022 | -106,000.00 |
| Jun 30, 2022 | -198,000.00 |
| Mar 31, 2022 | -102,000.00 |
| Dec 31, 2021 | 281,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 1,000.00 |